跳至主要内容
临床试验/CTRI/2011/07/001924
CTRI/2011/07/001924已完成3 期

Randomized Controlled Trial of Two different starting doses of Methotrexate in Rheumatoid arthritis - DMIRA

I0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with rheumatoid arthritis fulfilling the ACR 1987 criteria
  • 2.Between 18 years to 65 year of age
  • 3.Having active disease Disease activity score (28 joints) DAS28-3 more than 5.1
  • 4.Not on methotrexate in the last 2 months
  • 5.Permitted to be on corticosteroids if the dosages stable for at least 1 weeks before randomization and if corticosteroid dosage less than 10 mg/day
  • 6.Permitted to be on other disease modifying anti-rheumatic drug (DMARD) like sulfasalazine, leflunomide and hydroxychloroquine, if dosages stable for at least 2 weeks before randomization

排除标准

  • 1.Pregnant/Breastfeeding
  • 2.Ongoing/Recent treatment with methotrexate (2 months)
  • 3.Standard exclusion for MTX treatment
  • a.Chronic liver disease
  • b.Renal failure
  • c.Any leucopenia or thrombocytopenia
  • d.Breast-feeding
  • e.Desirous of pregnancy in the next 6 months
  • f.Known Hepatitis B or C positive
  • g.Known clinically relevant chronic lung disease: ILD
  • h.Tuberculosis or other active infections
  • i.Known HIV positive

研究者

发起方
I

相似试验